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Background: People with psychotic disorders have poor health, but studies have
shown that people who have a milder and more prevalent form of psychosis (psychotic
experiences) are also at risk for health problems. More research is needed to examine a
broad range of health conditions to discover new relations with psychotic experiences.
Methods: We analyzed cross-sectional data from the American Life Panel, a nationally
representative sample of the United States adult population. Using multivariable logistic
regression, we examined the associations between health conditions (categories of
conditions, specific conditions, count of conditions) and lifetime psychotic experiences.
Results: Approximately 71% of the weighted sample reported at least one health
condition, and around 18% reported a lifetime psychotic experience. Using multivariable
logistic regression, we found that several health conditions were associated with
psychotic experiences, including pain due to other causes, neck pain, other injury, any
gastrointestinal/kidney problem, liver diseases/cirrhosis, any nervous/sensory problem,
migraine, nerve problem causing numbness/pain, any other disorder, specifically sleep
disorder, chronic fatigue syndrome, and chronic pain. Further, the count of specific
health conditions and the count of categories were associated with greater odds of
psychotic experiences.
Conclusion: We found that numerous health conditions were associated with
psychotic experiences.
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INTRODUCTION
Hallucinatory experiences and delusional ideations can occur in the general population without
being distressful or impairing to a clinically significant degree (1). The prevalence of psychotic
experiences has been estimated to be around 7%, though it can be higher or lower depending
on the country (2–4). Most people who report psychotic experiences only experience them on a
few occasions: One large study consisting of 31,261 adults from 18 countries found that 32.2% of
respondents with lifetime psychotic experiences reported only one occurrence, and 31.8% reported
only two to five occurrences (3). Moreover, most people who have psychotic experiences do not
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develop a psychotic disorder [though prior studies have shown
psychotic experiences are associated with more persistent forms
of psychosis (5)]. Still, psychotic experiences have been a topic
of public health discussion because they are cross-sectionally
associated with numerous negative mental and physical health
outcomes, including disability (6, 7), poor quality of life (8),
suicidal thoughts and behaviors (9), medication consumption
and hospital admissions (10), and premature mortality (11).
While it is widely accepted that people with psychotic
disorders are at risk for chronic health conditions (12) and
shorter lives (13, 14), an emerging body of literature has
shown that those with psychotic experiences are also at risk
for poor physical health. Moreno et al. (10) analyzed the
World Health Organization (WHO) World Health Survey,
and found that angina, asthma, arthritis, tuberculosis,
vision or hearing problems, mouth/teeth problems, alcohol
consumption, smoking, and accidents were associated with
psychotic experiences, with the number of health conditions
increasing with the number of psychotic experiences. Using
these same data, Stubbs et al. (12) found that in 48 low- and
middle-income countries, psychotic experiences were associated
with 2.20 times greater odds for multimorbidity (aOR: 2.20;
95% CI: 2.02–2.39). Scott et al. (15) analyzed the WHO World
Mental Health Surveys and found that psychotic experiences
were significantly associated with subsequent onset of arthritis,
back or neck pain, frequent or severe headache, other chronic
pain, heart disease, high blood pressure, diabetes and peptic
ulcer. In the United States, Oh et al. (16, 17) found that certain
health conditions (stroke, epilepsy, arthritis, frequent/severe
headaches, chronic back/neck pain, other chronic pain, heart
disease, high blood pressure, asthma, ulcers, fertility problems,
hearing problems, vision problems, allergies/infections) were
related to psychotic experiences, with varying levels of strength
and significance depending on the racial/ethnic group, and with
evidence that the odds of psychotic experiences increased with
the number of health conditions in a dose-response fashion.
Aims of the Study
In this study, we built on existing literature by analyzing data
from a representative sample of the United States general
population to study the associations between physical health
conditions and psychotic experiences, using a wide range of




This study analyzed publicly available data from the RAND
American Life Panel (ALP) (18), which is a US nationally
representative probability-based panel consisting of ∼6,000
adults aged 18 and older. These panel members were recruited
using probability sampling methods [e.g., address-based samples
and telephone (random-digit dial) samples]. To enhance
representativeness, RAND provides computers and internet
service to members who would not otherwise be able to
participate. In 2019, RAND administered two surveys drawing
respondents from the panel: the first was the ALP Omnibus
Survey (N = 2,555) conducted in February-April, which had a
completion rate of 64.9%; and the second was the Health and
Functional Capacity Survey (N = 2,657) conducted April–June,
which had a completion rate of 78.2%. All of the panel members
who completed the ALP Omnibus Survey were included in
the Health and Functional Capacity Survey, allowing us to
merge the two data sets to yield a final sample of N = 2,554
for the current study. Sampling weights were constructed to
account for non-response and probability of selection using
population distributions from the Current Population Survey
Annual Social and Economic Supplement (provided by the U.S.
Census Bureau). Data collection and survey protocols were
approved by RAND’s Human Subjects Protection Committee,
which serves as RAND’s Institutional Review Board.
Measures
Lifetime Psychotic Experiences (Dependent)
Psychotic experiences were measured using an abbreviated
version of the WHO Composite International Diagnostic
Interview (CIDI) Psychosis Screen, which has been used in large
global epidemiology studies (3). Respondents were asked if they
had ever experienced the following: (1) A feeling something
strange and unexplainable was going on that other people would
find hard to believe?; (2) A feeling that people were too interested
in you or that there was a plot to harm you?; (3) A feeling that
your thoughts were being directly interfered or controlled by
another person, or your mind was being taken over by strange
forces?; and (4) An experience of seeing visions or hearing
voices that others could not see or hear when you were not
half asleep, dreaming, or under the influence of alcohol or
drugs? Endorsing any of these experiences constituted lifetime
psychotic experience.
Health Conditions (Independent)
Respondents were asked (yes/no): “Do you suffer from any of
the following serious health problems?” The list of conditions
included 10 categories of disorders, which were: (1) Blood
disorders; (2) Bone, joint, muscle, skin problems; (3) Cancer; (4)
Diabetes; (5) Gastrointestinal or kidney problems; (6) Heart of
circulatory problems; (7) Infectious diseases; (8) Lung problems;
(9) Nervous or sensory problems; and (10) other disorders.
Each category contained specific conditions, which are listed
in Table 1.
Sociodemographic Characteristics (Covariates)
Sociodemographic characteristics included age (18–25, 26–44,
45–64, 65+), sex (male, female), education (less than high
school, some high school but no diploma, high school graduate
or equivalent, some college but no degree, professional school
degree, Associate’s degree, Bachelor’s degree, Master’s degree,
Doctoral degree), income (<$25,000, $25,000–49,999, $50,0000–
74,999, $75,000–99,999, $100,000–124,999, $125,000–199,999,
$200,000, or more), and race/ethnicity (White, Black, Latinx,
Other). All sociodemographic characteristics can be found in
Supplementary Table 1.
Frontiers in Psychiatry | www.frontiersin.org 2 January 2021 | Volume 11 | Article 612084
Oh et al. Health and Psychotic Experiences
TABLE 1 | Prevalence of physical health conditions among people with and without lifetime psychotic experiences.
Total PE No PE Chi-square P-value
Condition N (%) N (%) N (%)
Blood disorders
Any blood disorder 52 (2.04) 13 (2.90) 39 (1.85) 2.04 0.15
Sickle cell anemia 5 (<0.00) 4 (0.95) 1 (0.21) 13.68 0.00
Other blood disorder 47 (1.93) 9 (2.13) 38 (1.89) 0.10 0.75
Bone, joint, muscle or skin problem
Any bone, joint, muscle or skin problem 1337 (52.35) 264 (58.93) 1073 (50.95) 9.43 0.00
Arthritis 782 (32.11) 145 (34.28) 637 (31.68) 1.09 0.27
Rheumatoid arthritis 81 (3.33) 16 (3.78) 65 (3.23) 0.33 0.55
Back pain due to spinal stenosis 167 (6.86) 30 (7.09) 137 (6.81) 0.04 0.83
Back pain due to other causes 663 (27.24) 166 (39.24) 497 (24.71) 37.22 0.00
Neck pain 399 (16.39) 117 (27.66) 282 (14.02) 47.42 0.00
Fibromyalgia 83 (3.41) 24 (5.67) 59 (2.93) 7.96 0.00
Lupus 20 (0.82) 5 (1.18) 15 (0.75) 0.81 0.39
Amputation of limb 13 (0.53) 3 (0.71) 10 (0.50) 0.30 0.52
Deformity of limb 8 (0.33) 1 (0.24) 7 (0.35) 0.13 0.72
Ehlers-Danlos syndrome 2 (<0.00) 1 (0.24) 1 (<0.00) 1.48 0.22
Severe burn 4 (0.16) 3 (0.71) 1 (<0.00) 9.26 0.00
Other bone or joint disorder 178 (7.31) 38 (8.98) 140 (6.96) 2.11 0.13
Other injury 139 (5.71) 37 (8.75) 102 (5.07) 8.76 0.00
Other muscle or connective tissue disorder 93 (3.82) 23 (5.44) 70 (3.48) 3.64 0.07
Cancer
Cancer 101 (4.15) 15 (3.55) 86 (4.28) 0.47 0.51
Diabetes
Diabetes 333 (13.68) 61 (14.42) 272 (13.53) 0.24 0.61
Gastrointestinal or kidney problem
Any gastrointestinal or kidney problem 385 (15.07) 93 (20.76) 292 (13.87) 13.71 0.00
Chron’s disease 15 (0.62) 6 (1.42) 9 (0.45) 5.38 0.01
Ulcerative colitis 24 (0.99) 8 (1.89) 16 (0.80) 4.30 0.03
Liver disease/cirrhosis 14 (0.58) 7 (1.65) 7 (0.35) 10.43 0.00
Chronic kidney disease (not on dialysis) 48 (1.97) 13 (3.07) 35 (1.74) 3.21 0.10
Chronic kidney disease (on dialysis) 7 (0.29) 2 (0.47) 5 (0.25) 0.61 0.43
Other gastrointestinal disorder 245 (10.07) 55 (13.00) 190 (9.45) 4.88 0.03
Other kidney or bladder disorder 75 (3.08) 17 (4.02) 58 (2.88) 1.50 0.24
Heart or circulatory problem
Any heart or circulatory problem 320 (12.53) 56 (1.25) 264 (12.54) 0.00 0.98
Heart failure 48 (1.97) 8 (1.89) 40 (1.99) 0.02 0.89
Coronary artery disease 81 (3.33) 7 (1.65) 74 (3.68) 4.45 0.04
Heart valve dysfunction 35 (1.44) 7 (1.65) 28 (1.39) 0.17 0.71
Peripheral arterial disease 42 (1.73) 7 (1.65) 35 (1.74) 0.01 0.90
Abnormal heart rhythm 34 (1.40) 4 (0.95) 30 (1.49) 0.76 0.39
Lymphedema 24 (0.99) 6 (1.42) 18 (0.90) 0.98 0.34
Other heart or circulatory system disorder 152 (6.24) 34 (8.04) 118 (5.87) 2.81 0.10
Infectious disease
Any infectious disease 51 (2.00) 15 (3.35) 36 (1.71) 5.07 0.02
HIV 19 (0.78) 7 (1.65) 12 (0.60) 5.05 0.02
Hepatitis 13 (0.53) 4 (0.95) 9 (0.45) 1.63 0.20
Other infectious diseases 21 (0.86) 5 (1.18) 16 (0.80) 0.61 0.43
Lung problem
Any lung problem 341 (13.35) 83 (18.53) 258 (12.25) 12.58 0.00
Asthma 241 (9.90) 58 (13.71) 183 (9.10) 8.33 0.01
(Continued)
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TABLE 1 | Continued
Total PE No PE Chi-square P-value
Condition N (%) N (%) N (%)
Chronic obstructive pulmonary disease/emphysema 76 (3.12) 13 (3.07) 63 (3.13) 0.00 0.95
Interstitial lung disease/pulmonary fibrosis 2 (<0.00) 0 (0.00) 2 (<0.00) 0.42 0.52
Pulmonary hypertension 33 (1.36) 8 (1.89) 25 (1.24) 1.10 0.30
Other lung disease 33 (1.36) 10 (2.36) 23 (1.14) 3.89 0.05
Nervous or sensory problem
Any nervous or sensory problem 656 (25.69) 163 (36.38) 493 (23.41) 32.58 0.00
Spinal cord injury 24 (0.99) 6 (1.42) 18 (0.9) 0.98 0.39
Multiple sclerosis 18 (0.74) 5 (1.18) 13 (0.65) 1.36 0.26
Seizure disorder 10 (0.41) 1 (0.24) 9 (0.45) 0.38 0.54
Parkinson’s disease 7 (0.29) 2 (0.47) 5 (0.25) 0.61 0.44
Stroke (or effects of a prior stroke) 36 (1.48) 9 (2.13) 27 (1.34) 1.48 0.21
Migraine 245 (10.07) 73 (17.26) 172 (8.55) 29.25 0.00
Blindness 13 (0.53) 1 (0.24) 12 (0.60) 0.85 0.36
Deafness 49 (2.01) 8 (1.89) 41 (2.04) 0.04 0.84
Nerve problem causing numbness or pain 349 (14.34) 91 (21.51) 258 (12.83) 21.45 0.00
Other nervous system disorder 58 (2.38) 17 (4.02) 41 (2.04) 5.90 0.02
Other disorders
Any other disorder (obesity, sleep, pain, immune,
other health)
804 (31.48) 195 (43.53) 609 (28.92) 36.55 0.00
Obesity 431 (17.71) 100 (23.64) 331 (16.46) 12.37 0.00
Sleep disorder 281 (11.54) 82 (19.39) 199 (9.90) 30.82 0.00
Chronic fatigue syndrome 48 (1.97) 19 (4.49) 29 (1.44) 16.81 0.00
Chronic pain 189 (7.76) 61 (14.42) 128 (6.36) 31.67 0.00
Immune deficiency 24 (0.99) 6 (1.42) 18 (0.90) 0.98 0.32
Other health problem 169 (6.94) 33 (7.80) 136 (6.76) 0.58 0.42
Psychiatric and Substance Use Disorders
(Covariates)
Psychiatric disorders are highly comorbid with psychotic
experiences (19), including depression and anxiety (19, 20),
which are also associated to several physical health conditions
(21). In keeping with prior studies (15–17), we adjusted
for the presence of psychiatric and substance use disorders.
Psychiatric disorder was coded dichotomously to reflect the
presence of at least one of the following self-reported conditions:
schizophrenia, bipolar disorder, depression, anxiety, attention
deficit/hyperactivity disorder, post-traumatic stress disorder,
Alzheimer’s disease, other dementia, other mental or cognitive
disorder. Substance use disorder was also coded dichotomously
to reflect the presence of at least one of the following conditions:
alcohol dependence, opioid dependence, other substance use
disorder). The descriptive summary of psychiatric disorders and
substance use disorders is presented in Supplementary Table 3.
Analysis
We calculated the total prevalence of health conditions
and lifetime psychotic experiences. We then examined the
prevalence of health conditions among those with and without
psychotic experiences, testing whether the proportions were
significantly different across categories. We then conducted
simple bivariate logistic regression models examining the
associations between each health condition and psychotic
experiences (see Supplementary Table 2), and then conducted
multivariable logistic regression models controlling for basic
sociodemographic characteristics (age, sex, education, income,
and race/ethnicity) (Supplementary Figure 1). Final models
included full adjustments for sociodemographic characteristics,
psychiatric disorder, and substance use disorder (Figure 1). We
used complete case analyses, allowing sample sizes to vary
according to data available, with <5% (n = 124) missing
in any given model. Due to small cell counts (n < 10),
several conditions could not produce reliable estimates, thus the
following conditions were included in the broader categories but
were not presented in Figure 1: severe burn, deformity of limb,
Alzheimer’s Disease, interstitial lung disease/pulmonary fibrosis,
Ehlers-Danlos Syndrome, chronic kidney disease (on dialysis),
and sickle cell anemia. We then examined the total count of




About 70.68% (N = 1,806) of the weighted sample reported
at least one health condition (95% CI; 68.59–72.70). The
most common category of condition was bone/joint/muscle/skin
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FIGURE 1 | Multivariable logistic regression showing associations between health conditions and lifetime psychotic experiences. All models are adjusted for age, sex,
education, income, race/ethnicity, psychiatric disorder, and substance use disorder. *p < 0.05; **p < 0.01; ***p < 0.001.
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problems, while the least common categories of conditions were
infectious diseases and blood disorders. Approximately 17.54%
(N = 448) reported a lifetime psychotic experience (95% CI
15.84–19.39). All sociodemographic characteristics of the sample
can be found in Supplementary Table 1. In brief, around a fifth
of the sample was young adults and over a third was older adults.
The majority (∼57%) of the sample was female and most of the
sample was educated (∼86% had at least some college or higher),
with nearly 40% of the sample earning a household income of
under $50,000 and over a third earning over $100,000. Most of
the sample (∼71%) was racially White. Over a quarter of the
sample had at least one psychiatric or substance use disorder.
Bivariate associations between health conditions and lifetime
psychotic experiences are shown in the Supplementary Table 2.
Multivariable logistic regression models with simple adjustments
for sociodemographic characteristics only (i.e., without
adjustments for psychiatric disorder or substance use disorder)
can also be found in the Supplementary Figure 1. All fully
adjusted models are shown in Figure 1.
Blood Disorders
Blood disorders were not significantly associated with
psychotic experiences.
Bone, Joint, Muscle, or Skin Problems
With only basic adjustments for sociodemographic
characteristics, having any bone/joint/muscle/skin problem
was associated with 1.52 times greater odds of psychotic
experiences, adjusted for age, sex, education, income, and race
(aOR: 1.52; 95% CI: 1.22–1.91). Specifically, these problems
included arthritis, back pain (due to other causes), neck pain,
fibromyalgia, other muscle/connective tissue disorder, and
other injury. Certain conditions were not associated with
psychotic experiences, including rheumatoid arthritis, back pain
due to spinal stenosis, lupus, amputation of limb, and other
bone/joint disorder. After adjustments for psychiatric disorder
and substance use disorder, however, only back pain due to other
causes (aOR: 1.43; 95% CI: 1.13–1.82), neck pain (aOR: 1.80; 95%
CI: 1.38–2.36), and other injury (aOR: 1.65; 95% CI: 1.08–2.52)
were significantly associated with psychotic experiences.
Cancer
Cancer was not significantly associated with
psychotic experiences.
Diabetes
Diabetes was not significantly associated with
psychotic experiences.
Gastrointestinal or Kidney Problems
With only basic adjustments for sociodemographic
characteristics, having any gastrointestinal/kidney problem
was associated 1.59 times greater odds of psychotic experiences
(aOR: 1.59; 95% CI: 1.21–2.08). Specific significant conditions
were Crohn’s Disease, liver disease/cirrhosis, and other
gastrointestinal disorder, and non-significant conditions were
ulcerative colitis, chronic kidney disease (on and off dialysis),
or other kidney/bladder disorder. However, after adjustments
for psychiatric disorders and substance use disorders, only any
gastrointestinal or kidney problem (aOR 1.40; 95% CI: 1.06–1.86)
and liver disease/cirrhosis (aOR: 4.66; 95% CI: 1.64–13.23) were
significantly associated with psychotic experiences.
Heart or Circulatory Problems
Having any heart/circulatory problem was not significantly
associated with psychotic experiences, nor was any specific type
of problem (e.g., failure, coronary artery disease, heart valve
dysfunction, peripheral arterial disease, abnormal heart rhythm,
and lymphedema), with the exception of “other heart/circulatory
system disorder” (aOR: 1.66; 95% CI: 1.09–2.53). However, after
adjustments for psychiatric disorder and substance use disorder,
this association was no longer significant. Further, coronary
artery disease was associated with lower odds of psychotic
experiences (aOR: 0.42; 95% CI: 0.19–0.95).
Infection Diseases
Having “any infectious disease” was not associated with psychotic
experiences, except for Human Immunodeficiency Virus (HIV),
which was no longer significant after adjustments for psychiatric
disorder and substance use disorder.
Lung Problems
With only adjustments of sociodemographic characteristics,
having “any lung problem” was associated with 1.43 times
greater odds of psychotic experiences (aOR: 1.43; 95% CI: 1.09–
1.88), though specific significant conditions such as asthma,
chronic obstructive pulmonary disease/emphysema, pulmonary
hypertension, and other lung disease, were not associated with
psychotic experiences. After adjustments for psychiatric disorder
and substance use disorder, none of the lung problems were
associated with psychotic experiences.
Nervous or Sensory Problems
With only adjustments of sociodemographic characteristics,
having any nervous/sensory problem was associated with 1.74
times greater odds of having psychotic experiences (aOR: 1.74;
95% CI: 1.34–2.25). Specific significant conditions included
migraine, nerve problem causing numbness or pain, and other
nervous system disorder. Conditions that were not associated
with psychotic experiences were spinal cord injury, multiple
sclerosis, seizure disorder, Parkinson’s disease, stroke, blindness,
and deafness. After adjustments for psychiatric disorders and
substance use disorders, only any nervous or sensory problems
(aOR: 1.52; 95% CI: 1.16–1.99), migraine (aOR: 1.45; 95%
CI: 1.05–1.99), and nerve problem causing numbness or
pain (aOR: 1.57; 95% CI: 1.15–2.13) were associated with
psychotic experiences.
Other Disorders
With only adjustments of sociodemographic characteristics,
other health problems were associated with 1.88 times greater
odds of psychotic experiences (aOR: 1.88; 95% CI: 1.30–
2.36). Conditions in this category that were associated with
psychotic experiences included obesity, sleep disorder, chronic
fatigue syndrome, chronic pain, other health problem. Immune
deficiency was not associated with psychotic experiences. After
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adjustments for psychiatric disorder and substance use disorder,
only any other disorder (aOR: 1.48; 95% CI: 1.18–1.86),
sleep disorder (aOR: 1.59; 95% CI: 1.17–2.16), chronic fatigue
syndrome (aOR: 2.01; 95% CI: 1.09–3.70) and chronic pain
(aOR: 1.64; 95% CI: 1.15–2.34) were significantly associated with
psychotic experiences.
Count of Conditions
Having any health condition was associated with 1.38 times
greater odds of psychotic experiences (aOR: 1.38; 95% CI: 1.03–
1.83), adjusting for sociodemographic characteristics, psychiatric
disorder, and substance use disorder. A one-condition increase in
the total number of specific conditions was associated with 1.09
times greater odds of psychotic experiences (aOR: 1.09; 95% CI:
1.05–1.13), and a one-category increase in the number of types
of conditions was associated with a 1.18 times greater odds of
psychotic experiences (aOR: 1.18; 95% CI: 1.09–1.28).
DISCUSSION
Summary of Findings
In this representative sample of the U.S., we found that several
physical health conditions were significantly associated with
lifetime psychotic experiences, adjusting for sociodemographic
characteristics. However, many associations attenuated and lost
significance after adjusting for psychiatric disorder and substance
use disorder. In the end, the only health conditions associated
with psychotic experiences were specific bone/join/muscle/skin
problems (such as back pain due to other causes, neck pain,
other injury, but not any other specific condition within
this category), any gastrointestinal/kidney problem (though
not specific conditions within this category except for liver
diseases/cirrhosis), any nervous/sensory problem (though not
specific conditions within this category except for migraine
and nerve problem causing numbness/pain), any other disorder
(specifically sleep disorder, chronic fatigue syndrome, and
chronic pain, but not other conditions within this category).
Also, the continuous count of specific health conditions and
categories of conditions were associated with greater odds of
psychotic experiences. Our findings align with existing studies
that show significant associations between psychotic experiences
and a range of health conditions (15–17, 22). In particular,
our study seemed to highlight prior findings that psychotic
experiences are related to pain conditions (15, 16, 23–25).
However, our study also offered novel contributions, as it
was among the first (to our knowledge) to show that liver
diseases/cirrhosis and chronic fatigue syndrome were related to
psychotic experiences.
Numerous statistically significant associations were
rendered non-significant after adjusting for sociodemographic
characteristics, and even more so after adjusting for psychiatric
disorder and substance use disorder, suggesting that much
of the associations between health conditions and psychotic
experiences may be partially explained by aspects of mental
health. Ultimately, we did not find significant associations for
several categories of health conditions, including blood disorders,
cancer, diabetes, infectious diseases, and lung problems. It is
possible that conditions were not significant due to a lack of
statistical power, resulting in false negatives, which is notable
since the majority of effect sizes generally suggested greater odds
of psychotic experiences. The non-significant associations for
cancer and diabetes is puzzling given that the health behaviors
that contribute to these conditions are also related to psychotic
experiences [e.g., tobacco use (26, 27)]. The non-significant
association between cardiovascular diseases and psychotic
experiences was also unexpected given prior studies (17, 28, 29).
We also did not find that seizures or strokes were associated with
psychotic experiences, which again, contradicted prior studies
(16, 30). We were the first to use representative data to examine
whether blindness was associated with psychotic experiences,
and found null results likely due to the small cell count, though
some have hypothesized that early blindness is actually protective
against psychosis (31).
Health conditions are often inter-related and share risk
factors, obfuscating the exact pathways by which specific physical
health conditions and psychotic experiences are connected. Stress
and chronic activation of the hypothalamic-pituitary-adrenal axis
can have adverse effect on health (32–34) and may underlie
the associations we found in our study. Further, given that we
found several pain-related conditions were linked to psychotic
experiences, inflammation may be implicated (35, 36). Along
these lines, microglia (i.e., immune cells in the central nervous
system that play a key role in inflammation) have been related
to health problems (37, 38), and their activation can result in
excessive synaptic pruning, loss of cortical gray matter, and
loss of cortical control, which may lead to the disinhibition
of subcortical dopamine and the occurrence of hallucinatory
experiences (39, 40). However, the link between inflammation
and psychotic experiences is not always clear (41) and future
research should elucidate the physiological pathways by which
health conditions and psychotic experiences are related.
Limitations
This study has several limitations. First, the data are cross-
sectional and did not allow us to ascertain the temporal
order of events (i.e., whether psychotic experiences preceded
the health conditions, or vice versa). Prospective cohort
studies are needed to sort out the directionality of the
associations we found in our study. Second, the CIDI was
only used to assess psychotic experiences, and all other health
conditions were self-reported and subject to biases. People
may have had undiagnosed health problems or otherwise
underreported their health conditions (especially if symptoms
were mild). Future studies can employ clinical/structured
interviews, or conduct surveys within healthcare systems so
that administrative data can be used to link health conditions
documented in medical records and insurance claims to
psychotic experiences. Third, due to small cell counts, several
associations may have been underpowered. For this reason,
we were unable to examine some specific health conditions
and were unable to differentiate the subtypes of psychotic
experiences. It is possible that health outcomes may have
been differentially related to hallucinatory experiences and
delusional ideations (42).
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Conclusions and Implications
There is reason to believe that psychotic experiences are cross-
sectional indicators of psychological distress (43, 44), as a
meta-analysis found that people with psychotic experiences
were more than twice as likely to report mental health
service use when compared with people without psychotic
experiences (45). Further, there is evidence to suggest that
psychotic experiences predict subsequent contact with mental
health services (46). Psychotic experiences may also be cross-
sectional indicators of physical distress as well, as one study
found that psychotic experiences were associated with several
subsequent chronic health conditions (15). In agreement with
prior cross-sectional studies, a significant portion of the
general population will report having a psychotic experience
at some point in life, and these experiences, as we have
shown in this study, are linked to several physical health
outcomes. Psychotic experiences are also associated with
health behaviors (e.g., smoking, sleep disturbance), which are
strongly predictive of subsequent health problems (47, 48).
It is important to consider that psychotic experiences often
happen for the first time in young adulthood [median age
of 26 years old (49)], which is potentially years or even
decades before symptoms of certain chronic health conditions
emerge. However, there has been little translational work
to assess the utility of psychotic experiences in predicting
subsequent chronic health conditions. Thus, it has yet to be
determined whether psychotic experiences can signal physical
and psychological distress in such a way that they effectively
guide the selection and timing of preventive interventions.
In conclusion, more prospective cohort studies are needed to
ascertain the predictive utility of psychotic experiences, and
clinicians should be aware that many health conditions are
associated with psychotic experiences.
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